Valuation : MicroPort Scientific Corporation

Market Cap 1.49B 11.65B 1.28B 1.2B 1.1B 2.05B 141B 2.06B 14.24B 5.51B 72B 5.58B 5.46B 229B P/E 2026 *
17.1x
P/E 2027 * 16.6x
Enterprise Value 2.23B 17.45B 1.91B 1.8B 1.64B 3.07B 211B 3.08B 21.33B 8.25B 108B 8.36B 8.18B 343B EV / Sales 2026 *
1.9x
EV / Sales 2027 * 1.63x
Free-Float
61.84%
Yield 2026 *
-
Yield 2027 * -
01/09 MicroPort Scientific Corporation Delays Earnings Results Release for the Six Months Ended June 30, 2026 CI
29/08 MicroPort Scientific Corporation Announces Board and Committee Changes, Effective August 28, 2026 CI
13/08 MicroPort Scientific Expects to Record Loss in H1 MT
13/08 MicroPort Scientific Corporation Provides Preliminary Consolidated Earnings Guidance for the Six Months Ended 30 June 2026 CI
16/07 MicroPort Scientific Unit Eyes Sale of Controlling Stake in Orthopedics Business MT
01/07 MicroPort Scientific Corporation Appoints Dr. Yingyao Chen as an Independent Non-executive Director CI
27/05 Microport Scientific Corporation Announces Appointment of Greg Holman to Chief Commercial Officer CI
21/05 Bayzed Health Unit Partners With MicroPort Units on Smart Healthcare Services MT
20/05 Bayzed Medical Investment Group Company Limited, Wholly Owned Subsidiary of Bayzed Health Group Inc Enters into Strategic Cooperation Agreements with Shanghai Weichuang Weilian Weitong Health Management Co., Ltd. and Shanghai Mingyue Medical Technology Co., Ltd, Subsidiaries of MicroPort Scientific Corporation CI
30/04 MicroPort Scientific Corporation Auditor Raises 'Going Concern' Doubt CI
29/04 Microport Scientific says qtrly net profit attributable for Shanghai Microport Endovascular Medtech (Group) RMB154.8 mln RE
09/04 Microport Cardioflow Medtech Corporation and Microport Scientific Corporation Enter Distribution Agreements for International Markets CI
02/04 Nomura Adjusts MicroPort Scientific's Price Target to HK$9.85 From HK$8.81, Keeps at Neutral MT
1 day-2.64%
1 month-12.34%
3 months-13.21%
6 months-41.59%
Current year-43.85%
1 month 5.88
Extreme 5.88
7.34
Current year 5.83
Extreme 5.83
14.16
1 year 5.83
Extreme 5.83
16.28
3 years 4.46
Extreme 4.46
16.28
5 years 4.46
Extreme 4.46
52.75
10 years 4.46
Extreme 4.46
72.85
Manager TitleAgeSince
Chief Executive Officer 51 27/06/2025
Chief Executive Officer 63 20/09/2012
Director of Finance/CFO 51 01/09/2012
Director TitleAgeSince
Chairman 63 06/10/2011
Director/Board Member 62 03/09/2010
Director/Board Member 69 03/09/2010
Date Insider Type Main position Quantity % Market Cap. Importance
7/1/26 Other

Chief Executive Officer

400,000 0.0209%
5/1/26 Other

Chief Executive Officer

500,000 0.0261%
2/1/26 Other

Chief Executive Officer

1,400,000 0.0732%
Change 5-day change 1-year change 3-year change Capi.($)
-2.64%0.00%-57.81%-51.17% 1.49B
-1.75%+0.42%+23.66%+16.35% 223B
-1.17%-0.82%+3.32%-17.37% 144B
-4.51%-5.17%-25.50%+17.42% 124B
-5.90%-6.45%-58.41%-16.50% 65.19B
-3.54%-4.43%+8.12%+17.08% 49.99B
+0.98%-0.76%-17.96%-12.69% 50.49B
-2.66%-2.05%+14.61%+28.83% 41.4B
-1.58%-0.72%+30.24%+52.87% 39.59B
-3.28%+1.90%+114.97%+33.28% 31.87B
Average -2.03%-2.04%+3.52%+6.81% 77.09B
Weighted average by Cap. -1.42%-1.80%+4.76%+8.69%

Financials

2026 *2027 *
Net sales 1.17B 9.19B 1.01B 948M 865M 1.61B 111B 1.62B 11.23B 4.34B 56.77B 4.4B 4.3B 181B 1.34B 10.49B 1.15B 1.08B 988M 1.84B 127B 1.85B 12.82B 4.96B 64.84B 5.02B 4.91B 206B
Net income 84.77M 665M 72.89M 68.57M 62.58M 117M 8.04B 117M 812M 314M 4.11B 318M 311M 13.07B 89.63M 703M 77.06M 72.5M 66.16M 123M 8.5B 124M 859M 332M 4.34B 337M 329M 13.82B
Net Debt 740M 5.8B 636M 599M 546M 1.02B 70.15B 1.02B 7.09B 2.74B 35.86B 2.78B 2.72B 114B 693M 5.43B 596M 560M 511M 954M 65.67B 959M 6.64B 2.57B 33.57B 2.6B 2.54B 107B
Logo MicroPort Scientific Corporation
Microport Scientific Corp Microport Scientific Corp is an investment holding company mainly engaged in the sale, manufacture, research and development (R&D) of medical devices. The Company operates in eight segments. The Cardiovascular Devices Business segment includes implantable devices and access devices. The Orthopedics Devices Business segment includes reconstructive joints and spine products. The Cardiac Rhythm Management (CRM) Business segment includes pacemakers and defibrillators. The Endovascular and Peripheral Vascular Devices Business segment includes L-REBOA aortic occlusion balloons. The Neurovascular Devices Business segment includes cerebral atherosclerotic stenosis and coil products. The Structural Heart Disease Business segment includes Transcatheter Aortic Valve Implantation. The Surgical Robot Business segment includes the manufacture and R&D of surgical robot devices. The Surgical Devices Business segment includes the manufacture and R&D of surgical devices.
Employees
6,547
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.7750USD
Average target price
1.800USD
Spread / Average Target
+132.24%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!